96723 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
Methods for the directed expansion of epitopes for use as antibody ligands
#302COSMETIC OR DERMATOLOGICAL PREPARATIONS COMPRISING OLIGOPEPTIDES FOR LIGHTENING THE SKIN OF AGE MARKS AND/OR FOR PREVENTING TANNING OF THE SKIN, IN PARTICULAR TANNING OF THE SKIN CAUSED BY UV RADIATION
#303Peptides Capable of Functioning as Mimotopes for Hormonal Analytes
#304Immunoregulatory compositions
#305Biochemical method for specific protein labeling
#306Growth Hormone Secretagogue Receptor 1A Ligands
#307C-Met receptor regulation by angiotensin IV (AT) receptor ligands
#308Fish cancer model
#309Treatment of trauma-hemorrhage with short oligopeptides
#310Prodrug compounds with isoleucine
#311Peptide compositions
#312Antineoplastic peptides
#313Method of producing FR901228
#314Hiv Prodrugs Cleavable by Cd26
#315Gene introduction efficiency enhancer
#316HCV PROTEASE INHIBITORS
#317Peptidomimetic agents from dextrorotatory amino acids as well as pharmaceutical agents that contain the latter for treatment of neurodegenerative diseases
#318Activatable photodynamic therapy agents
#319Gene regulator
#320Treatment of burns
#321BIOLOGICALLY ACTIVE PEPTIDE VAPEEHPTLLTEAPLNPK DERIVATIVES
#322Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability
#323Therapeutic administration of the scrambled anti-angiogenic peptide C16Y
#324Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives
#325ABUSE-RESISTANT HYDROCODONE COMPOUNDS, COMPOSITIONS AND METHODS OF USING THE SAME
#326IMMUNOREGULATORY COMPOSITIONS
#327Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#328Alpha-fetoprotein peptides and uses thereof
#329Compositions and methods for promoting myocardial and peripheral angiogenesis
#330Organic compounds and their uses
#331Prodrugs cleavable by CD26
#332Modulators of beta-amyloid peptide aggregation comprising D-amino acids
#333Compositions capable of reducing elevated blood urea concentration
#334Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids
#335Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier
#336Oligopeptide acetate and formulations thereof
#337Osteogenic proteins
#338Pyrrolidine melanocortin-specific compounds
#339Synthesis of peptide α-thioesters
#340Methods for reducing CD36 expression
#341Metabolite derivatives of the HDAC inhibitor FK228
#342Didemnin analogs and fragments and methods of making and using them
#343Orally administered small peptides synergize statin activity
#344Treatment of ischemic events
#345Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases
#346Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
#347Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
#348Prodrug compounds with isoleucine
#349Peptide Conjugates and Fluorescence Detection Methods for Intarcellular Caspase Assay
#350Treatment of dry eye
#351Method of treating interferon non-responders using HCV protease inhibitor
#352Compounds for inhibiting cathepsin activity
#353Peptide conjugates and fluorescence detection methods for intracellular caspase assay
#354Means for preventing and treating cellular death and their biological applications
#355Peptides directed for diagnosis and treatment of amyloid-associated disease
#356Method of designing physiologically active peptide and use thereof
#357G-type peptides and other agents to ameliorate atherosclerosis and other pathologies
#358Mucin hypersecretion inhibitors and methods of use
#359Aza-peptide epoxides
#360Heparin-binding peptides and uses thereof
#361Pyrrolidine derivatives for use in treating heaptitis c virus infection
#362Partial peptide mimetics and methods
#363Smart pro-drugs of serine protease inhibitors
#364Peptides for use in culture media
#365Glycopeptide and peptide having a taste imparting function, and method of imparting the taste to foods
#366Neurotrophic and neuroprotective peptides
#367Modulators of β-amyloid peptide aggregation comprising D-amino acids
#368Antineoplastic peptides
#369Connective tissue stimulating peptides
#370Molecular interactions in cells
#371Peptides and their use to ameliorate cell death
#372Method of making tetrapeptide derivative TZT-1027 crystal
#373Use of deltaPKC peptides for modulation of reactive oxygen species
#374Gene regulatory peptides
#375Compositions and methods for determining substrate specificity of hydrolytic enzymes
#376Peptidomimetic protease inhibitors
#377Peptides for use in culture media
#378Dipeptide inhibitors of β-secretase
#379Selective substrates for matrix metalloproteinases
#380Protein variants having modified immunogenicity
#381Peptides as NS3-serine protease inhibitors of hepatitis C virus
#382Depsipeptide and congeners thereof for use as immunosuppressants
#383Orally administered small peptides synergize statin activity
#384Compositions and methods for promoting myocardial and peripheral angiogenesis
#385Compounds and methods for modulating functions of classical cadherins
#386Antibody conjugate methods for selectively inhibiting VEGF
#387Methods of selecting immunoregulator peptides obtained from gonadotropins
#388Method for purification of a protein complex and identification of its components
#389Translating bifocal wear modality
#390Elastin peptide analogs and uses thereof
#391Elastin peptide analogs and uses thereof
#392Methods and uses for protein breakdown products
#393Hypoglycaemic peptides and methods of use thereof
#394Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
#395Methods for forming peptides and peptide conjugates and peptides and peptide conjugates compositions formed thereby